| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 09/15/2009 | US7588760 Binds to a denatured collagens but not to native triple helical forms of the collagen; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists |
| 09/11/2009 | WO2009109751A1 Crystalline phospholipid, method for its production and use in treating damaged tissue |
| 09/11/2009 | CA2717066A1 Crystalline phospholipid, method for its production and use in treating damaged tissue |
| 09/10/2009 | US20090227669 Compositions and Methods for Perioperative Bladder Instillation |
| 09/10/2009 | US20090226437 Humanized anti-beta7 antagonists and uses therefor |
| 09/03/2009 | WO2009106368A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
| 09/03/2009 | CA2716807A1 Postsurgical adhesion barriers |
| 09/03/2009 | CA2716400A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
| 09/01/2009 | US7582778 Podophyllotoxin |
| 09/01/2009 | US7582440 Imaging, diagnosis and treatment of disease |
| 09/01/2009 | CA2255657C Solution and process for resuscitation and reparation of ischemically damaged tissue |
| 08/27/2009 | WO2009105165A2 Cardioplegia solution for cardiac surgery |
| 08/27/2009 | WO2009104802A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 08/27/2009 | WO2009104005A1 Chronic wound treatment |
| 08/27/2009 | CA2715638A1 Cardioplegia solution for cardiac surgery |
| 08/27/2009 | CA2714215A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 08/26/2009 | CN101513439A Notoginseng sodium hyaluronate gel for preventing from adhesion after spine laminectomy |
| 08/25/2009 | CA2215356C Novel embolizing compositions |
| 08/19/2009 | EP1280566B1 Growth factor modified protein matrices for tissue engineering |
| 08/19/2009 | EP1255829B1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/13/2009 | WO2008098364A8 Reducing post-operative adhesion formation with intraperitoneal glutamine |
| 08/13/2009 | DE102008008522A1 Implantierbare Nanopartikel-enthaltende Produkte Implantable nanoparticle-containing products |
| 08/12/2009 | EP2086589A2 Ultrasound microbubble mediated genes delivery system |
| 08/12/2009 | EP1149111B1 Method and composition for angiogenesis inhibition |
| 08/12/2009 | CN101502509A Medicament for repairing mesothelium, endothelium and epidermal tissue, as well as preventing adhesions and obstruction, and preparation method |
| 08/12/2009 | CN100525778C Novel post-operation antiadhesive materials and its preparation method |
| 08/11/2009 | CA2391539C Use of poly(diallylamine) polymers |
| 08/06/2009 | US20090196876 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/06/2009 | US20090196844 Composition for inhibiting adhesion |
| 08/06/2009 | CA2714387A1 Extracellular matrix compositions |
| 08/05/2009 | CN101500409A Improved tissue maintenance |
| 07/30/2009 | WO2009033774A3 Use of a laminin nonapeptide as a therapeutic agent |
| 07/30/2009 | US20090191572 Imaging, diagnosis and treatment of disease |
| 07/29/2009 | EP2082755A1 Monolithic alginate implants networked in situ |
| 07/29/2009 | EP1347805B1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/28/2009 | CA2435159C A method of preparing a collagen sponge |
| 07/23/2009 | WO2009090020A1 Monolithic in-situ cross-linked alginate implants |
| 07/23/2009 | WO2009033773A3 Use endothelin 2, alone or combined with a nonapeptide, a peptide as a therapeutic agent |
| 07/23/2009 | US20090186062 Method of Repairing Meniscal Tears |
| 07/23/2009 | DE102008005172A1 Composition, useful for producing an agent for intraoperative application in abdominal cavity to prevent postoperative adhesion, comprises two components of polysaccharide, hyaluronic acid and/or phospholipid, and an antiinflammatory agent |
| 07/23/2009 | CA2709868A1 Monolithic alginate implants crosslinked in situ |
| 07/22/2009 | EP2079301A1 Improved tissue maintenance |
| 07/16/2009 | US20090181958 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions |
| 07/16/2009 | US20090181937 Cross-linked fatty acid-based biomaterials |
| 07/15/2009 | EP2078532A1 Medical device comprising a haemostatic agent and haemostatic kit comprising the medical device |
| 07/15/2009 | EP1141015B1 Insulin-like growth factor (igf) i mutant variants |
| 07/14/2009 | US7560558 quinoline pyridyl derivatives antagonist; antitumor agents; renal disease, hepatic fibrosis, cirrhosis, fibroid lung, scleroderma, wound healing, arthritis, congestive cardiac disease, ulcer, ocular disorder, cornea disorder, diabetic nephropathy |
| 07/14/2009 | US7560280 Human cord blood derived unrestricted somatic stem cells (USSC) |
| 07/09/2009 | WO2008040002A3 Methods, compositions and articles of manufacture for hif modulating compounds |
| 07/09/2009 | US20090175946 Use of gelatin and a cross-linking agent for producing cross-linking medical glues |
| 07/09/2009 | CA2710382A1 Treatment of orthopedic conditions |
| 07/09/2009 | CA2710375A1 Treatment of orthopedic conditions |
| 07/09/2009 | CA2710227A1 Treatment of surgical adhesions |
| 07/09/2009 | CA2710223A1 Treatment of surgical adhesions |
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/07/2009 | US7556801 Pluripotent somatic stem cells for use in regenerative medicine; use in treatment of vascular disease, Parkinson's disease, diabetes |
| 07/02/2009 | WO2009080899A2 Products and methods affecting cell and tissue growth |
| 07/02/2009 | US20090170835 Isoindoline derivatives |
| 07/01/2009 | CN100506815C Piperidinyl targeting compounds that selectively bind integrins |
| 06/24/2009 | EP1324767B1 Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery |
| 06/17/2009 | EP2071020A2 Tissue Implant |
| 06/17/2009 | EP1322592B2 Substituted 1-aminobutan-3-ol derivatives |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | CN100497314C Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 06/04/2009 | US20090143319 Transcription factor decoy |
| 06/04/2009 | US20090142311 Engineered intervertebral disc tissue |
| 06/04/2009 | US20090142295 Anti-Connexin Compounds and Uses Thereof |
| 05/28/2009 | WO2009066746A1 Material for preventing tissue adhesion and material for preventing joint contracture |
| 05/28/2009 | US20090136468 Peri-operative composition comprising lactobacillus rhamnosus |
| 05/27/2009 | CN101439206A Preparation of enzyme-catalyzed rapid-solidified hydrogel and use thereof |
| 05/27/2009 | CN100490822C Gelatin for preventing conglutination in the surgical and the method for preparing the same |
| 05/21/2009 | US20090131338 Anesthesia arousal composition |
| 05/21/2009 | US20090130221 Decellularisation of tissue matrices for bladder implantation |
| 05/20/2009 | CN101433712A Liver perfusate and preparation method thereof |
| 05/14/2009 | US20090124617 Quinolone derivative or salt thereof |
| 05/14/2009 | US20090123581 Collagen cross-linking agents on dental restorative treatment and preventive dentistry |
| 04/30/2009 | US20090111734 Compositions and methods for promoting hemostasis and other physiological activities |
| 04/23/2009 | US20090105315 Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as s1p receptor agonists |
| 04/22/2009 | CN101411738A Novel operation antiblocking liquor |
| 04/22/2009 | CN100480375C Human cord blood derived unrestricted somatic stem cells (USSC) |
| 04/21/2009 | CA2434964C Carrier with solid fibrinogen and solid thrombin |
| 04/21/2009 | CA2157855C Benzoylguanidines substituted by heterocyclic n-oxide, process for their preparation, their use as a medicament or diagnostic agent, medicament containing them and intermediate products for their preparation |
| 04/16/2009 | WO2008040002A9 Methods, compositions and articles of manufacture for hif modulating compounds |
| 04/15/2009 | CN101406457A Process for the manufacture of a pharmaceutical product |
| 04/15/2009 | CN100478027C Catheter composition and uses thereof for preparing medicine |
| 04/09/2009 | US20090093617 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 04/08/2009 | EP1499329B1 Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass |
| 04/08/2009 | CN100475843C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 04/08/2009 | CN100475837C Branched polyglycol-amino acid oligopeptide and active derivative and medicinal composition thereof |
| 04/07/2009 | US7514541 crosslinking with curing agents in acidic or alkaline conditions, to form to products used in cosmetic, medical and pharmaceutical applications |
| 04/07/2009 | CA2387888C Local prevention or amelioration of pain from surgically closed wounds |
| 04/07/2009 | CA2372384C Anti-inflammatory bioactive glass particulates |
| 03/26/2009 | US20090082267 Prevention and Reduction of Blood Loss |
| 03/25/2009 | EP1353692B1 Methods and compositions for treatment of ocular neovascularization and neural injury |
| 03/25/2009 | CN100471842C Quinolone derivative or its salt |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/19/2009 | US20090076257 Ester Derivatives of Hyaluronic Acid for the Preparation of Hydrogel Materials by Photocuring |
| 03/19/2009 | US20090075911 Ester Derivatives of Hyaluronic Acid for the Preparation of Hydrogel Materials by Photocuring |
| 03/19/2009 | US20090075866 Reducing hypotensive events experienced by normovolemic subject during surgery while under general anesthesia via modified hemoglobin |
| 03/18/2009 | EP1453810B1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |